Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Clark, MD
Allena Pharmaceuticals Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
113 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medizinische Universitat Wien, Innere Medizin Iii
Vienna, Austria
- Uvc Brugmann University Hospital- Centre Hospitalier Universitaire
Brussels, Belgium
- Universite Libre de Bruxelles -Hospital Erasme
Brussels, Belgium
- University Hospital Gent
Ghent, Belgium
- Hospital Das Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
- Hospital Das Clinicas Da Ufmg
Belo Horizonte, Brazil
- Faculdade de Medicina Do Abc
Santo André, Brazil
- Pesquisare Saude
Santo André, Brazil
- University of Alberta- Division of Urology
Edmonton, Alberta, Canada
- Silverado Research Inc
Victoria, British Columbia, Canada
- Centre de Recherche Du Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Alpha Recherche Clinique
Québec, Quebec, Canada
- Polyclinic Solme
Zagreb, Croatia
- Hopital Beaujon_ap_hp
Clichy, France
- Ap-Hm Hospital de la Conception
Marseille, France
- Hospital Tenon-Ap-Hp
Paris, France
- Chru de Nancy-Hopitaux de Brabois
Vandœuvre-lès-Nancy, France
- Charite Universitaetsmedizin- Berlin
Berlin, Germany
- Klinikum Der Universitaet- Muenche
München, Germany
- Azienda Usl Toscana Centro-Ospedale Santa Maria Nuova
Florence, Italy
- Irccs Azienda Ospedaliera Universitaria San Martino Ist
Genova, Italy
- Fondazione Policlinico Universitario A.Gemelli Irccs - Universita Cattolica del Sacro Cuore
Rome, Italy
- Invesclinic Mx
Irapuato, Gto, C.P, Mexico
- Icaro Investigaciones En Medicina Sa de Cv/hospital Christus Muguerza
Chihuahua City, Mexico
- Clinstile, S.A. de C.V- Col. Roma Norte Delegacion
Cuauhtémoc, Mexico
- Centro Specializado En Diabetes, Obesidad Y Prevencion de Enfermedades Cardiovasculares
Mexico City, Mexico
- Hospital Fernando Da Fonseca
Amadora, Portugal
- Centro Hospitalar Universitario de Sao Joao
Porto, Portugal
- Institutul Clinic Fundeni
Bucharest, Romania
- Sana Medical Center
Bucharest, Romania
- Spitalul Clinic Universitar de Urgenta Bucuresti
Bucharest, Romania
- Clintrial/county Hospital Caracal
Caracal, Romania
- Centru de Diagnostic Si Tratament Affidea- Medicina Interna
Constanța, Romania
- Clinic of Urology Llc
Penza, Russia
- City Hospital #15
Saint Petersburg, Russia
- Llc Medsi St Petersburg
Saint Petersburg, Russia
- Medical Center "reavita Med Stp" Llc
Saint Petersburg, Russia
- S.M Kirov Military Medical Academy
Saint Petersburg, Russia
- Saratov State Medical University, N.A. V.I. Razumosky
Saratov, Russia
- Fundacio Puigvert
Barcelona, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Aug 2019
- Primary completion
- 19 May 2022
- Completion
- 19 May 2022
- Last update posted
- 10 Jun 2022
- Registered enrollment
- 92
- Registry id
- NCT03847090
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.